Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523808
Recruitment Status : Completed
First Posted : February 1, 2012
Last Update Posted : March 8, 2013
Information provided by (Responsible Party):
ERYtech Pharma